Pycnogenol Study Shows Potential Pain Relief Benefits
A six-month clinical trial reports improved vitality and pain scores for women with bone density disorders using Pycnogenol.
Updated on Oct. 16, 2026 in Nutrition
Live Poll
Do you trust dietary supplements to effectively manage your chronic pain or improve your vitality?
A clinical trial conducted through January 2024 evaluated the effects of Pycnogenol supplementation on 67 women diagnosed with osteopenia or osteoporosis. Participants receiving 100 mg of the supplement twice daily reported improved bodily pain and vitality scores compared to a placebo group.
Why it matters
Researchers sought to determine if Pycnogenol could improve quality of life and safety profiles in patients with bone density issues. The trial results offer preliminary insights into the potential physical benefits of the supplement for this patient demographic.
In a clinical trial of 67 female patients, those receiving 100 mg of Pycnogenol twice daily showed a decline in serum phosphate levels from 1.20 to 1.12 mmol/L. Researchers observed no moderate or serious adverse events throughout the six-month study.
The players
Horphag Research
This organization provided the educational grant that funded the clinical trial.
The details
The randomized study split participants into two groups with average ages of 60.7 and 63.1 years and mean BMIs of 24.8 and 24.2 kg/m², respectively. While the Pycnogenol group showed significant improvements in the SF-36v2 bodily pain domain, there was no overall difference in quality-of-life metrics between the two cohorts.
Timeline
October 2021 to January 2024: Enrollment of study participants.
3 months: Duration of the initial treatment phase.
6 months: Total duration of the clinical trial.
Health Landscape
The study employs the SF-36v2 Health Survey to quantify patient-reported outcomes, placing these findings within the established framework for measuring health-related quality of life. This approach aligns with standardized clinical research protocols used to evaluate therapeutic interventions.
The trial results suggest that Pycnogenol may offer pain and vitality benefits, though patients should consult healthcare providers before adding supplements to their routines. Further research is necessary to assess whether such supplementation affects long-term bone density or fracture risk.
The takeaway
While this study notes improvements in specific pain and vitality domains, it does not confirm a broader enhancement in general quality of life. Patients looking to manage bone density disorders should continue to prioritize clinically proven treatments and discuss all supplementation with their medical team.
Further reading
For more information on dietary supplements and health studies, visit our Nutrition section.
Source note: This article includes information reported by News-Medical.
Live Poll
Do you trust dietary supplements to effectively manage your chronic pain or improve your vitality?
